Skip to main content
OpenTrials

Clinical trial condition

Endometrial Cancer

Explore clinical trials studying Endometrial Cancer. Study availability and eligibility vary by location and protocol.

619 public trials 193 recruiting studies
Refine in advanced search Browse all conditions

Endometrial Cancer trial results

Completed

Safety, Tolerability & Potential Anti-cancer Activity of Increasing Doses of AZD5363 in Different Treatment Schedules

NCT01226316

Conditions
AKT1, Adnexal Diseases, Advanced Solid Malignancy, +46 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Stanford, California, United States
  • Research Site West Hollywood, California, United States
  • Research Site Aurora, Colorado, United States
View all 34 locations
View Trial Details
Completed

ZW25 in Women With Endometrial Cancers

NCT04513665

Conditions
Carcinosarcoma, Endometrial Cancer, Endometrial Neoplasms, +15 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited protocol activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited protocol activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited protocol activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities) Commack, New York, United States
View Trial Details
Completed

Atezolizumab Trial in Endometrial Cancer - AtTEnd

NCT03603184

Conditions
Endometrial Cancer, Endometrial Neoplasms, Female Urogenital Diseases, +10 more
Locations
  • Royal Adelaide hospital Adelaide, Australia
  • Border Medical Oncology Research Unit Albury, Australia
  • Icon Cancer Centre Auchenflower, Australia
  • Pindara Private Hospital Benowa, Australia
View all 93 locations
View Trial Details
Completed

A Study of LY2880070 in Participants With Advanced or Metastatic Cancer

NCT02632448

Conditions
Adnexal Diseases, Breast Cancer, Breast Diseases, +55 more
Locations
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Tom Baker Cancer Centre Calgary, Alberta, Canada
  • Cross Cancer Institute Edmonton, Alberta, Canada
View all 16 locations
View Trial Details
Completed

Study of XB002 in Subjects With Solid Tumors (JEWEL-101)

NCT04925284

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +57 more
Locations
  • Exelixis Clinical Site #48 Birmingham, Alabama, United States
  • Exelixis Clinical Site #20 Tucson, Arizona, United States
  • Exelixis Clinical Site#95 Tucson, Arizona, United States
  • Exelixis Clinical Site#58 Little Rock, Arkansas, United States
View all 95 locations
View Trial Details

Related conditions